FBXO30 Antibodies

Santa Cruz Biotechnology offers a broad range of FBXO30 monoclonal antibodies for research focused on understanding FBXO30 protein functions. FBXO30 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBXO30, a member of the F-box protein family, plays a critical role in the ubiquitin-proteasome pathway, which is essential for regulating protein degradation and maintaining cellular homeostasis. FBXO30 is involved in various cellular processes, including cell cycle regulation and signal transduction, making it significant in cancer research and other diseases. Understanding FBXO30 functions can provide insights into its potential as a therapeutic target. Researchers worldwide utilize FBXO30 monoclonal antibodies to advance their studies in protein degradation pathways. FBXO30 monoclonal antibodies enable detailed investigation of cellular mechanisms and disease processes. The reliability and specificity of Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to scientific knowledge and therapeutic development.